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Purpose: The aim of the present study was to assess both the credibility and strength of evidence arising from systematic reviews with meta-anal-
yses of observational studies on handgrip strength and health outcomes.
Methods: An umbrella review of systematic reviews with meta-analyses of observational studies was conducted. We assessed meta-analyses of
observational studies based on random-effect summary effect sizes and their p values, 95% prediction intervals, heterogeneity, small-study
effects, and excess significance. We graded the evidence from convincing (Class I) to weak (Class IV).
Results: From 504 articles returned in a search of the literature, 8 systematic reviews were included in our review, with a total of 11 outcomes. Overall,
9 of the 11 of the outcomes reported nominally significant summary results (p< 0.05), with 4 associations surviving the application of the more strin-
gent p value (p< 106). No outcome presented convincing evidence. Three associations showed Class II evidence (i.e., highly suggestive): (1) higher
handgrip values at baseline were associated with a minor reduction in mortality risk in the general population (n = 34 studies; sample size = 1,855,817;
relative risk = 0.72; 95% confidence interval (CI): 0.670.78), (2) cardiovascular death risk in mixed populations (n = 15 studies; relative risk = 0.84;
95%CI: 0.780.91), and (3) incidence of disability (n = 7 studies; relative risk = 0.76; 95%CI: 0.660.87).
Conclusion: The present results show that handgrip strength is a useful indicator for general health status and specifically for early all-cause and
cardiovascular mortality, as well as disability. To further inform intervention strategies, future research is now required to fully understand mech-
anisms linking handgrip strength scores to these health outcomes.
2095-2546/ 2020 Published by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
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A decline in physical function is a natural phenomenon that
is associated with aging.1 Such a decline is a public health con-
cern because it has been shown to be associated with increasedis an open access article under the CC BY-NC-ND license.
lla review of systematic reviews with meta-analyses of observational studies, Journal of
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2 P. Soysal et al.risk of falls,2 health care use,3 level of dependency,4 and pre-
mature mortality.5 Indeed, for many independent older adults,
everyday tasks, such as climbing stairs, require functioning
close to maximal capacity, meaning that further decline could
increase their risk of becoming dependent on a carer.6 One
widely employed measure of physical functioning is handgrip
strength. The handgrip strength test is commonly used to eval-
uate the integrated performance of the muscles by determining
the maximal grip force that can be produced in 1 muscular
contraction, which further serves as a marker for general mus-
cle strength.7 Handgrip strength is a valid measure of physical
function and has been widely employed in observational
research and clinical settings.811 Importantly, 1 study found
that dynamometer-determined handgrip strength could be a
useful instrument in geriatric practice to identify the “oldest
old” patients (i.e., those aged over 75 years) at risk of
disability.12
In recent years there has been an exponential increase in the
literature investigating associations between handgrip strength
and health outcomes (e.g., depression,13 cognitive function,14
suicidal ideation,15 mobility limitations,16 falls,17 cardiovascu-
lar disease,18 diabetes,19 renal outcomes,20 osteoporotic fac-
tors,21 multimorbidity,22 and mortality23); consequently, there
has been an increase in systematic reviews with meta-analyses.
However, to date, most systematic reviews have focused on a
single disease end-point, and there has not been a systematic
evaluation of the relationships between handgrip strength and
diverse physical and mental health outcomes. Moreover, the
strength and reliability of the evidence presented in the litera-
ture is unclear.
To address the breadth of the literature of physiological
measurements and outcomes, an increasing emphasis has been
placed on “umbrella reviews” (i.e., the syntheses of existing
systematic reviews with meta-analyses in order to capture the
breadth of outcomes associated with a given exposure).
Given this situation, the aim of the present study was to
carry out an umbrella review of existing systematic reviews
with meta-analyses of handgrip strength and all health out-
comes in order to systematically assess the quality and strength
of the evidence across all health outcomes and to identify those
studies with the strongest evidence.2. Methods
This umbrella review was registered in PROSPERO:
(https://www.crd.york.ac.uk/PROSPERO/display_record.
php?RecordID=158547).
2.1. Data sources and searches
We conducted an umbrella review24 by first searching sev-
eral databases (MEDLINE, Scopus, and Embase) from incep-
tion until 20 November 2019. The following search terms
were used: (“meta-analysis”[ptyp] OR “metaanaly*”[tiab] OR
“meta-analy*”[tiab] OR “systematic review”[ptyp] OR
“systematic review” [tiab]) AND “handgrip” [tiab]). In addi-
tion, we hand-searched the reference lists of eligible articles.Please cite this article as: Pinar Soysal et al., Handgrip strength and health outcomes: Umbre
Sport and Health Science (2020), https://doi.org/10.1016/j.jshs.2020.06.0092.2. Study selection
In this umbrella review, we included systematic reviews
and/or meta-analyses of observational studies that investigate
the relationship between handgrip strength and any health out-
come. Specific inclusion criteria included the following: (1)
meta-analyses or systematic reviews containing sufficient data
for a meta-analysis (as defined by the authors) that measured
handgrip strength and ascertained health outcomes using self-
report (e.g., depression questionnaires), observed (e.g., clinical
diagnoses), or objective (e.g., biomarkers and mortality) crite-
ria; (2) case control studies or cohort studies (retrospective and
prospective cohorts); and (3) meta-analyses of cohort studies
that investigated the association between handgrip strength
with any health-related outcome (e.g., cardiovascular disease,
cancer, death, obesity/overweight, mental illness, diabetes,
and metabolic diseases). Studies had to report these outcomes
as odds ratio, relative risk (RR), hazard ratio, or continuous
data. Two authors (PS and CH) independently performed title
and abstract screening in couples. Disagreements were
resolved through consensus with another independent author
(LS).2.3. Data extraction
Four independent investigators (PS, LS, CH, and NV)
extracted in pairs the following information for each article:
first author name, year of publication, journal, the number of
included studies and the total number of participants included
in the studies reviewed, the inclusion criteria for the studied
populations, the measures by which handgrip strength was
captured, how handgrip strength was categorized, the effect
sizes used in the review, the subgroupings used in the meta-
analysis, the study design (case control, retrospective, and pro-
spective), the number of cases and controls for each study, and
health outcomes.
We then extracted the study-specific estimated RR for
health outcomes (RR, odds ratio, hazard ratio, standardized
mean difference), along with the 95% confidence interval (CI),
and the number of cases for each study by subjects and con-
trols. If 2 reviews covered the same association, we included
the review with the largest number of studies.2.4. Risk of bias assessment
Two authors (PS and CH) independently rated the methodo-
logical quality of the included systematic reviews using “A
MeaSurement Tool to Assess systematic Reviews 2
(AMSTAR2)”,25 which ranks the quality of a meta-analysis in
one of 4 categories ranging from “critically low” to “high”
according to 16 predefined items. The review is ranked as high
quality if it has no or 1 noncritical weakness (the systematic
review provides an accurate and comprehensive summary of
the results of the available studies that address the question of
interest). The review is ranked as moderate quality if it has
more than 1 noncritical weakness (the systematic review has
more than 1 noncritical weakness but no critical flaws; it may
provide an accurate summary of the results of the availablella review of systematic reviews with meta-analyses of observational studies, Journal of
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as low quality if it has 1 critical flaw with or without noncriti-
cal weaknesses (the review has a critical flaw and may not pro-
vide an accurate and comprehensive summary of the available
studies that address the question of interest). Finally, the
review is ranked as critically low quality if it has more than 1
critical flaw with or without noncritical weaknesses (the
review has more than 1 critical flaw and should not be relied
on to provide an accurate and comprehensive summary of the
available studies).26 For further reading relating to the
AMSTAR 2 and what constitutes a critical flaw or a critical
weakness, and so on, we refer the reader to the following
reference.26
2.5. Statistical analysis
For each meta-analysis, we estimated the summary effect
size and its 95%CI through random-effects models.27 We
also estimated the prediction interval and its 95%CI, which
further accounts for between-study effects and estimates the
certainty of the association if a new study addresses that
same association.28 Between-study association was estimated
with the I2 metric; values of 50% or greater are indicative of
high heterogeneity, while values above 75% suggest very
high heterogeneity.29
In addition, we calculated the evidence of small-study
effects (i.e., whether small studies would have inflated effect
sizes compared to larger ones). To this end, we used the regres-
sion asymmetry test developed by Egger and co-workers.30 A
p value of less than 0.10, with more conservative effects in
larger studies than in random-effects meta-analysis, was con-
sidered as indicative of small-study effects.21 Finally, we
applied Ioannidis’s excess of significance test to evaluate
whether there was an excess of studies reporting statistically
significant results.31
2.6. Grading the evidence
We used the credibility assessment criteria, which are based
on established tools for observational evidence as summarized
previously.24,3235 We classified evidence from meta-analyses
of observational studies with nominally statistically significant
summary results (p < 0.05) into 4 categories (Class I, II, III,
and IV). Associations were considered to be convincing (Class
I) if they had (1) a statistical significance of p value of less
than 106, (2) included more than 1000 cases (or more than
20,000 participants for continuous outcomes), (3) had the larg-
est component study reporting a significant result (p < 0.05),
(4) had a 95% prediction interval that excluded the null, (5)
did not have large heterogeneity (I2 < 50%), and (6) showed
no evidence of small study effects (p > 0.10) or of excess sig-
nificance bias (p > 0.10). Highly suggestive (Class II) evi-
dence was assigned to associations that (1) reported a
significance of p values of less than 0.001, (2) included more
than 1000 cases (or more than 20,000 participants for contin-
uous outcomes), and (3) had the largest component study
reporting a statistically significant result (p < 0.05). Sugges-
tive (Class III) evidence was assigned to associations thatPlease cite this article as: Pinar Soysal et al., Handgrip strength and health outcomes: Umbre
Sport and Health Science (2020), https://doi.org/10.1016/j.jshs.2020.06.009reported a significance of a p value of less than 0.01
with more than 1000 cases (or more than 20,000 participants
for continuous outcomes). Weak (Class IV) evidence was
assigned to the remaining significant associations with a
p value of less than 0.05.
Due to the inherent limitations of case control studies in
examining temporal associations, we had planned to provide
the classification of evidence for Class I and II based on the
following order: (1) meta-analyses of prospective studies and
(2) meta-analyses of prospective and retrospective case control
studies. However, no outcome had these characteristics.3. Results
3.1. Literature review
Our search identified 20 potentially eligible reviews. Of the
20 reviews, eight were deemed to be eligible for our umbrella
review. The 8 reviews had 11 different outcomes that were
included in our umbrella review.3.2. Meta-analyses of observational studies
The median number of studies of meta-analyses that
included observational studies for each outcome was 8 (range
434), the median number of participants was 23,064 (range
27751,855,817), and the median number of cases was 1823
(Table 1).
The majority of the meta-analyses included studies on the
general population or in adults older than 50 years, followed
by patients with cardiovascular disease. Overall, nine of the 11
outcomes reported nominally significant summary results (p <
0.05), with 4 associations surviving to the application of the
more stringent p value (p< 106) (Table 1). Heterogeneity
among studies was high in nine of the 11 of the outcomes
included, with 7 having an I2 of 75% or greater. Only 2 associ-
ations presented 95% prediction intervals excluding the null
value. Evidence for excess statistical significance was present
in 5 of 41 outcomes, and small-study effects were seen in 3 of
11 outcomes. Bias was present in three of the outcomes
included. The largest study, in terms of participants for each
outcome, was statistically significant in all the associations,
except one.
Based on the above criteria, no outcome presented convinc-
ing evidence. However, 3 associations showed Class II evi-
dence (i.e., highly suggestive): higher handgrip values at
baseline, were associated with a minor reduction in mortality
risk in the general population (n = 34 studies; sample
size = 1,855,817; RR = 0.72; 95%CI: 0.670.78); cardiovascu-
lar death in mixed populations (e.g., diabetes, general, and
other conditions) (n = 15 studies; RR = 0.84; 95%CI:
0.780.91), and incidence of disability (n = 7 studies;
RR = 0.76; 95%CI: 0.660.87) (Table 1). The other outcomes
were ranked as suggestive (association between higher hand-
grip values and chair rise performance over time) or weak (5
outcomes), with only 2 associations not statistically significant
(i.e., the association between handgrip strength and incident
hip fracture or cancer mortality) (Table 1).lla review of systematic reviews with meta-analyses of observational studies, Journal of
Table 1
Health outcomes and evidence class reported in included meta-analyses of observational studies.
Author of MAa Population Outcome Study
design
Number of
studies
Cases Sample
size
Effect
size
Mean
ES (95%CI)
p I2 Small
study
effects
Excess
significance
bias
Largest
study
significant
95%PI Class of
evidence
Garcıa-Hermoso
A et al. (2018)
General
population
All-cause
mortality
Cohort 34 57,854 1,855,817 RR 0.72 (0.670.78) 2.04E-18 83.5 Yes No Yes 0.521.00 II
Chainani V et al.
(2016)
Mixed CVD
mortality
Cohort/
clinical trials
15 2183 29,105 RR 0.84 (0.780.91) 0.00001 84.3 No No Yes 0.671.07 II
Vermeulen et al.
(2011)
Mixed Disability Cohort 7 1136 5201 RR 0.76 (0.660.87) 0.00009 89.9 Yes Yes Yes 0.51.16 II
Hardy R et al.
(2013)
Adults aged
50 years or older
Chair rise
performance
Cohort 8 NA 10,098 b 0.93 (0.651.21) 6.20E-11 91.0 No NA Yes 0.02 to 1.88 III
Hardy R et al.
(2013)
Adults aged
50 years or older
Walking speed Cohort 8 NA 7261 b 0.89 (0.611.17) 5.37E-10 88.4 No NA Yes 0.03 to 1.82 IV
Hardy R et al.
(2013)
Adults aged
50 years or older
Inability to
balance
Cohort 8 NA 11,318 OR 0.94 (0.920.98) 1.58E-09 76.2 No NA Yes 0.881.00 IV
Pavasini R et al.
(2018)
Patients with car-
diac disease
Cardiac death Cohort/clinical
trials
6 3000 23,435 OR 0.83 (0.740.94) 0.01 52.1 No Yes Yes 0.591.17 IV
Pavasini R et al.
(2018)
Patients with car-
diac disease
Hospital
admission for
HF
Cohort/
clinical trials
4 125 23,064 OR 0.88 (0.820.95) 0.01 14.3 No No Yes 0.711.10 IV
Hwang SH et al.
(2019)
Patients with
CKD undergoing
dialysis
Mortality Cohort 10 589 2775 RR 0.92 (0.870.98) 0.02 70.3 Yes No Yes 0.851.19 IV
Denk K et al.
(2018)
Adults aged
50 years or older
Hip fracture Case-control 12 1462 28,579 RR 1.32 (0.971.79) 0.08 90.8 No Yes Yes 0.503.47 NS
Garcıa-Hermoso
A et al. (2018)
Healthy youth and
adults
Cancer
mortality
Cohort 10 8887 1,297,163 RR 0.97 (0.921.07) 0.28 18.9 No No No 0.881.07 NS
Notes: Associations were considered to be convincing (Class I) if they had (1) a statistical significance of p < 106, (2) included more than 1000 cases (or more than 20,000 participants for continuous outcomes),
(3) had the largest component study reporting a significant result (p< 0.05), (4) had a 95%PI that excluded the null, (5) did not have large heterogeneity (I2< 50%), and (6) showed no evidence of small study effects
(p > 0.10) or of excess significance bias (p > 0.10). Highly suggestive (Class II) evidence was assigned to associations that (1) reported a significance of p < 0.001, (2) included more than 1000 cases (or more than
20,000 participants for continuous outcomes), and (3) had the largest component study reporting a statistically significant result (p < 0.05). Suggestive (Class III) evidence was assigned to associations that reported
a significance of p < 0.01 with more than 1000 cases (or more than 20,000 participants for continuous outcomes). Weak (Class IV) evidence was assigned to the remaining significant associations with p < 0.05.
a Please refer to the Supplementary File for reference list of included studies in the umbrella review.
Abbreviations: CI = confidence interval; CKD = chronic kidney disease; CVD = cardiovascular disease; ES = effect size; HF = heart failure; MA =meta-analyses; NA = not applicable; NS = not statistically signifi-
cant; OR = odds ratio; PI = prediction interval; RR = relative risk.
A
R
T
IC
L
E
IN
P
R
E
S
S
P
lease
cite
th
is
article
as:
P
in
ar
S
o
y
sal
et
al.,
H
an
d
g
rip
stren
g
th
an
d
h
ealth
o
u
tco
m
es:
U
m
b
rella
rev
iew
o
f
sy
stem
atic
rev
iew
s
w
ith
m
eta-an
aly
ses
o
f
o
b
serv
atio
n
al
stu
d
ies,
Jo
u
rn
al
o
f
S
p
o
rt
an
d
H
ealth
S
cien
ce
(2
0
2
0
),
h
ttp
s://d
o
i.o
rg
/1
0
.1
0
1
6
/j.jsh
s.2
0
2
0
.0
6
.0
0
9
4
P
.
S
o
y
sal
et
al.
ARTICLE IN PRESS
Handgrip strength and health outcomes 53.3. Quality assessment
Based on scores derived from using the AMSTAR 2 tool, a
total of 4 of the meta-analyses included in our review scored
“critically low” and 4 scored “low” (Supplementary Table 1).
Notably, most studies did not include a list of excluded studies
(n = 8) or report the source of funding for the included studies
(n = 7). Moreover, it should be noted that 1 study did not
include a systematic review.
4. Discussion
In this umbrella review of 8 meta-analyses and 11 health
outcomes investigating associations between handgrip strength
and all health outcomes, a total of 3 outcomes (lower all-cause
mortality, lower cardiovascular mortality, and lower risk of
disability) were found to have highly suggestive evidence.
One outcome (chair rise performance over time) was found to
have suggestive evidence. Five outcomes (walking speed,
inability to balance, hospital admissions, cardiac death, and
mortality in those with chronic kidney disease) were found to
have weak evidence. Importantly, 2 associations were found to
be nonsignificant (incident hip fracture and cancer mortality).
Taken together, these findings suggest that handgrip strength
is a useful indicator for general health status, early all-cause
mortality, cardiovascular mortality, disability, and leg power
(chair rise performance).
Several mechanisms may explain the relationship between
handgrip strength and early mortality. First, early life factors,
such as participation in sufficient levels of physical activity,
influence handgrip strength,36 and childhood levels of physical
activity and handgrip strength have been shown to track into
adulthood.37,38 Importantly, maintaining adequate levels of
physical activity and function over the entire life course likely
yields the greatest benefit to health, owing to the reduction of
any prolonged exposure from unhealthy behaviors. Next,
strength is related to muscle mass and muscle mass is used a
protein reserve during cases of trauma.39 Finally, other genetic
contributions may be at play that result in muscle dystrophy
and early mortality.40
When considering the relationship between handgrip
strength and disability and leg power, this may be explained
by sarcopenia (a progressive reduction in muscle strength and
mass, absolute and relative to body size, commonly occurring
with aging).41 Sarcopenia is associated with a decline in physi-
cal function and an increase in disability.8 Next, the handgrip
strength test is not just a pure measure of strength; and those
with joint disorders, who will likely have increased risk of dis-
ability and lower leg power, may perform worse when carrying
out this task.8
Umbrella reviews provide top-tier evidence and important
insights, but there are a number of limitations to our review
that should be considered. The meta-analyses contained stud-
ies that differed in their designs, populations, and other charac-
teristics. However, we applied an I2of less than 50% as one of
the criteria for Class I evidence (convincing) to assign the best
evidence grade only to robust associations. Next, meta-analy-
ses have inherent limitations:42 their findings depend on whichPlease cite this article as: Pinar Soysal et al., Handgrip strength and health outcomes: Umbre
Sport and Health Science (2020), https://doi.org/10.1016/j.jshs.2020.06.009estimates are selected from each primary study and how they
are applied in the meta-analysis. Finally, all the meta-analyses
included in our review scored low or critically low when
appraised through the use of the AMSTAR 2 tool, suggesting
that future meta-analyses in this area will require more accu-
rate reporting of methods and will also need to incorporate
more robust discussions around findings.5. Conclusion
Our results show that handgrip strength is a useful indicator
for general health status, early all-cause mortality, cardiovas-
cular mortality, disability, and leg power (chair rise perfor-
mance). Future research is needed to fully understand the
mechanisms linking handgrip strength scores to these health
outcomes and further inform intervention strategies.Authors’ contributions
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